Lesley in an Immunologist with over 19 years’ experience in Immunotherapy and Immune Oncology drug development. In her most recent role as Director Development Projects at F-star Biotechnology, she was responsible for building the development function, project management and successfully led a cross functional team to deliver a novel dual checkpoint inhibitor bispecific through preclinical studies into the clinic. Prior to F-star, in her role as Product Development Team Leader at Medimmune she led cross functional international teams and progressed 2 novel immune oncology agents through preclinical studies into Phase 1 clinical development. Lesley was also involved in leading multiple Oncology projects from discovery to candidate drug nomination in a project management role at Medimmune. Prior to Medimmune, Lesley was Head of Immunology at Celldex and Cellular Immunology at Lorantis Ltd where she respectively led teams developing targeted cancer vaccines and immune modulators of the Notch signalling pathway for autoimmune disease and asthma. Lesley has a PhD in Cellular Immunology focused on Class I antigen presentation and a BSc in Immunology from the University of Glasgow.